The benefit of chemotherapy in a patient with multiple brain metastases and meningitis carcinomatosa from ovarian cancer

Int J Clin Oncol. 2005 Feb;10(1):69-71. doi: 10.1007/s10147-004-0437-x.

Abstract

We report on a 45-year-old patient with stage IIIc ovarian cancer, multiple brain metastases, and meningitis carcinomatosa. After three courses of initial chemotherapy, consisting of docetaxel and carboplatin, the patient underwent interval cytoreductive surgery, consisting of hyster-ectomy, bilateral salpingo-oophorectomy, omentectomy, appendectomy, and retroperitoneal lymphadenectomy. Then five courses of the same chemotherapy were given as adjuvant treatment. At the completion of the primary therapy, she achieved a complete remission. Ten months after the completion of the initial treatment, multiple brain metastases with meningitis carcinomatosa were detected. After four courses of the same chemotherapy, she again had a complete response, confirmed by cranial enhanced magnetic resonance imaging (MRI), and she felt well, with relief from the debilitating neurologic symptoms for 4 months. After this 4 months, her disease recurred, with meningitis carcinomatosa, and she requested supportive care only. She died 4 months after this recurrence. Chemotherapy can help to prolong life for some patients with multiple brain metastases and meningitis carcinomatosa from ovarian cancer.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Brain Neoplasms / complications
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / secondary*
  • Carboplatin / administration & dosage
  • Carcinoma / complications
  • Carcinoma / drug therapy*
  • Carcinoma / secondary*
  • Docetaxel
  • Fatal Outcome
  • Female
  • Humans
  • Meningitis / drug therapy*
  • Middle Aged
  • Ovarian Neoplasms / complications
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / pathology*
  • Ovarian Neoplasms / surgery
  • Recurrence
  • Taxoids / administration & dosage

Substances

  • Taxoids
  • Docetaxel
  • Carboplatin